Abstract

We report a case of a 65-year old patient affected by neurofibromatosis 1, documented by the presence of germ-line mutation on the NF1 gene, who developed various hyperproliferative malignant and benign diseases. He was brought to our attention for the diagnosis of acute myeloid leukemia revealed by major fatigue and dyspnea. The disease characteristics at diagnosis were hyperleukocytosis and complex karyotype with the inversion of the chromosome 16, classifying as a high-risk leukemia. The association between leukemia and neurofibromatosis 1 is controversial and needs to be further investigated. Nevertheless, such patients present a wide number of comorbidities that make therapeutic strategies most difficult.

Highlights

  • We report a case of a 65-year old patient affected by neurofibromatosis 1, documented by the presence of germ-line mutation on the Neurofibromatosis type 1 (NF1) gene, who developed various hyperproliferative ly malignant and benign diseases

  • He was brought to our attention for the diagnosis of acute n myeloid leukemia revealed by major fatigue and o dyspnea

  • The associu ation between leukemia and neurofibromatosis l 1 is controversial and needs to be further invesia tigated. Such patients present a wide number of comorbidities that make therac peutic strategies most difficult. mer Introduction m Neurofibrosis type 1 o Neurofibromatosis type 1 (NF1), otherwise c known as Von Recklinghausen disease, is a - neurocutaneous genetic disorder with an auton somal dominant transmission

Read more

Summary

Acute myeloid leukemia

We report a case of a 65-year old patient affected by neurofibromatosis 1, documented by the presence of germ-line mutation on the NF1 gene, who developed various hyperproliferative ly malignant and benign diseases. He was brought to our attention for the diagnosis of acute n myeloid leukemia revealed by major fatigue and o dyspnea. The associu ation between leukemia and neurofibromatosis l 1 is controversial and needs to be further invesia tigated. Such patients present a wide number of comorbidities that make therac peutic strategies most difficult.

Case Report
Conclusions
Findings
Neurofibromatosis and childhood
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call